New pill shows promise against hard-to-treat lymphoma
NCT ID NCT06511895
First seen Jan 08, 2026 · Last updated May 22, 2026 · Updated 18 times
Summary
This study tested an oral drug called AZD4205 in 57 adults with peripheral T-cell lymphoma that returned or didn't respond to at least one prior therapy. The goal was to see if the drug could shrink tumors and how safe it was. Participants took one pill daily, and researchers measured tumor response using standard criteria.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL T-CELL LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Anhui Provincial Hospital (The First Affiliated Hospital of USTC)
Hefei, Anhui, China
-
Beijing Cancer Hospital
Beijing, Beijing Municipality, China
-
Chongqing Cancer Hospital
Chongqing, Chongqing Municipality, China
-
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, China
-
Hainan General Hospital
Haikou, Hainan, China
-
Henan Cancer Hospital
Zhengzhou, Henan, China
-
Hunan Cancer Hospital
Changsha, Hunan, China
-
Jiangsu Cancer Hospital
Nanjing, Jiangsu, China
-
Peking University Third Hospital
Beijing, Beijing Municipality, China
-
Ruijing Hospital, Shanghai Jiaotong University School of Medicine
Shanghai, Shanghai Municipality, China
-
Shandong Cancer Hospital & Insititution
Jinan, Shandong, China
-
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, China
-
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
-
The First Bethune Hospital of Jilin University
Changchun, Jilin, China
-
The Second Hospital of Anhui Meidcine University
Hefei, Anhui, China
-
Tianjin Medical University Cancer Institute & Hospital
Tianjin, Tianjin Municipality, China
-
Union Hospital Tongji Medical College Huazhong University of Science and Technology
Wuhan, Hubei, China
-
West China Hospital of Sichuan University
Chengdu, Sichuan, China
-
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China
Conditions
Explore the condition pages connected to this study.